Penn Medicine 2020 Updates in Oncology
2020 ASCO Update on Prostate Cancer: How Effective Are Recently FDA Approved Olaparib & Rucaparib for mCRPC With HRR-gene Defects? Does a Novel GnRH Antagonist Relugolix Look Promising?
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Vivek Narayan
By
Penn Medicine 2020 Updates in Oncology
FEATURING
Vivek Narayan
Login to view comments.
Click here to Login